Books on the topic 'Pharmaceutical industry Australia Case studies'

Science, politics, and the pharmaceutical industry. London: UCL Press, 1995.

Tapon, Francis. Case studies on the organization of pharmaceutical R & D: A preliminary report. [Toronto]: Ontario Centre for International Business Research Programme, 1991.

Barbosa, Alexandre de Freitas. A indústria farmacêutica brasileira e as exportações para a América Latina: Impactos dos acordos comerciais e das variáveis macroeconômicas. Brasília, DF, Brasil: Federação Brasileira da Indústria Farmacêutica, 2006.

Monte Carlo simulation for the pharmaceutical industry: Concepts, algorithms, and case studies. Boca Raton: CRC Press, 2011.

P, Millard Steven, and Krause Andreas, eds. Applied statistics in the pharmaceutical industry: With case studies using S-Plus. New York: Springer, 2001.

Donghi, Monica. Patent strategy in pharmaceutical industry: Are additional patents valuable? Baden-Baden: Nomos, 2014.

Zucker, Lynne G. Present at the revolution: Transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrourgh. Cambridge, MA: National Bureau of Economic Research, 1995.

Innovation in the making. Frederiksberg, Denmark: Samfundslitteratur, 2001.

Hide, Martin S. The management of buyer-supplier relationships in the pharmaceutical industry: A case study. Dublin: University College Dublin, 1996.

N, Denoncourt Rena, and Warner Anjli C, eds. U.S. vaccine markets: Overview and four case studies. Washington, D.C: AEI Press, 2009.

Weiss, Linda. Structure, strategy, and public policy: Lessons from the Italian textile industry for Australia. Kensington, N.S.W: Industrial Relations Research Centre, University of New South Wales, 1991.

Gassmann, Oliver. Leading pharmaceutical innovation: Trends and drives for growth in the pharmaceutical industry. Berlin: Springer, 2004.

Gassmann, Oliver. Leading pharmaceutical innovation: Trends and drivers for growth in the pharmaceutical industry. 2nd ed. Berlin: Springer, 2008.

Claire, Mayhew, and Peterson Chris L. 1949-, eds. Occupational health and safety in Australia: Industry, public sector and small business. St Leonards, N.S.W: Allen & Unwin, 1999.

Abraham, John. Science, politics and the pharmaceutical industry: Controversy and bias in drug regulation. London: UCL Press, 1995.

Science, politics, and the pharmaceutical industry: Controversy and bias in drug regulation. New York: St. Martin's Press, 1995.

Liping, Du. The marketing of traditional medicines in China. Lewiston, NY: Edwin Mellen Press, 2005.

Hörnell, Erik. Svenska aktier i utlandet: Fallet Pharmacia. [Stockholm]: SNS, 1988.

Zhan lüe guan li: Gou jian yi yao qi ye he xin jing zheng li de xin si wei. Changchun Shi: Jilin da xue chu ban she, 2010.

Zhan lüe guan li: Gou jian yi yao qi ye he xin jing zheng li de xin si wei. Changchun Shi: Jilin da xue chu ban she, 2010.

David, Finegold, ed. BioIndustry ethics. Boston, Mass: Elsevier Academic Press, 2005.

Coordinadora de Organizaciones no Gubernamentales para el Desarrollo (Spain), ed. Salud, medicamentos y tercer mundo. Madrid: Coordinadora de Organizaciones no Gubernamentales para el Desarrollo, Iepala Editorial, 1986.

The economics of competition: The race to monopoly. New York: Best Business Books, 2006.

Blood medicine: Blowing the whistle on one of the deadliest prescription drugs ever. New York: Plume, 2012.

Graciela, Gutman, and Vispo Adolfo, eds. La desregulación de los mercados: Paradigmas e inequidades de las políticas del neoliberalismo. Buenos Aires: Grupo Editorial Norma, 1999.

Rand Corporation. National Security Research Division, ed. The economic consequences of investing in shipbuilding: Case studies in the United States and Sweden. Santa Monica, Calif: RAND Corporation, 2015.

1959-, Sundgren Mats, ed. Venturing into the bioeconomy: Professions, innovation, identity. Houndmills, Basingstoke, Hampshire: Palgrave Macmillan, 2011.

Ahmadian, Siamak. Der produkttechnische Fortschritt: Eine theoretische und empirische Untersuchung dargestellt anhand eines neuen Produkts der schweizerischen pharmazeutischen Industrie. Freiburg, Schweiz: Universitätsverlag, 1988.

Pisano, Gary P. The development factory: Unlocking the potential of process innovation. Boston, Mass: Harvard Business School Press, 1997.

Boosting pharmaceutical innovation in the post-TRIPS era: Real-life lessons for the developing world. Cheltenham, UK: Edward Elgar, 2014.

Users and abusers of psychiatry: A critical look at traditional psychiatric practice. London: Routledge, 1989.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry: Hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session. Washington: U.S. G.P.O., 1993.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry: Hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session. Washington: U.S. G.P.O., 1993.

Office, General Accounting. Medicaid: States turn to managed care to improve access and control costs : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives. Washington, D.C: The Office, 1993.

Office, General Accounting. Medicaid: Tennessee's program broadens coverage but faces uncertain future : report to the Ranking Minority Member, Committee on Commerce, House of Representatives. Washington, D.C: The Office, 1995.

Office, General Accounting. Medicaid: Changes in best price for outpatient drugs purchased by HMOs and hospitals : fact sheet for the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives. Washington, D.C: The Office, 1994.

Office, General Accounting. Medicaid: Oregon's managed care program and implications for expansions : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives. Washington, D.C: The Office, 1992.

Office, General Accounting. Medicaid: Waiver program for developmentally disabled is promising but poses some risks : report to Congressional requesters. Washington, D.C: The Office, 1996.

Office, General Accounting. Medicaid: The Texas disproportionate share program favors public hospitals. Washington, D.C: U.S. General Accounting Office, 1993.

Office, General Accounting. Medicaid: States' efforts to educate and enroll beneficiaries in managed care : report to the Chairman, Special Committee on Aging, U.S. Senate. Washington, D.C: The Office ; Gaithersburg, Md. (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1996.

Office, General Accounting. Medicaid: Methods for setting nursing home rates should be improved : report to the Secretary of Health and Human Services. Washington, D.C: The Office, 1986.

Koenig, Stefan. Scalable Green Chemistry: Case Studies from the Pharmaceutical Industry. Jenny Stanford Publishing, 2013.

Scalable Green Chemistry: Case Studies from the Pharmaceutical Industry. Taylor & Francis Group, 2013.

Koenig, Stefan. Scalable Green Chemistry: Case Studies from the Pharmaceutical Industry. Jenny Stanford Publishing, 2013.

Magano, Javier, and Joshua R. Dunetz. Transition Metal-Catalyzed Couplings in Process Chemistry: Case Studies from the Pharmaceutical Industry. Wiley & Sons, Limited, John, 2013.

Magano, Javier, and Joshua R. Dunetz. Transition Metal-Catalyzed Couplings in Process Chemistry: Case Studies from the Pharmaceutical Industry. Wiley & Sons, Incorporated, John, 2013.

Magano, Javier, and Joshua R. Dunetz. Transition Metal-Catalyzed Couplings in Process Chemistry: Case Studies from the Pharmaceutical Industry. Wiley & Sons, Incorporated, John, 2013.

Magano, Javier, and Joshua R. Dunetz. Transition Metal-Catalyzed Couplings in Process Chemistry: Case Studies from the Pharmaceutical Industry. Wiley & Sons, Incorporated, John, 2013.

Green Chemistry In The Pharmaceutical Industry. Wiley-VCH Verlag GmbH, 2010.

Dunn, Peter J., Michael T. Williams, and Andrew Wells. Green Chemistry in the Pharmaceutical Industry. Wiley & Sons, Limited, John, 2010.